Intra-venous Zoledronic Acid Once Yearly
NCT00984893
·
clinicaltrials.gov ↗
COMPLETED
Status
1551
Enrollment
INDUSTRY
Sponsor class
Conditions
Post-Menopausal Osteoporosis
Interventions
DRUG:
zoledronic acid
DRUG:
Any oral bisphosphonates marketed in Canada
Sponsor
Novartis Pharmaceuticals